Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
Wang A, Karunasinghe N, Plank LD, Zhu S, Osborne S, Brown C, Bishop K, Schwass T, Tijono S, Holmes M, Masters J, Huang R, Keven C, Ferguson LR, Lawrenson R. Wang A, et al. Among authors: masters j. Sci Rep. 2021 Jul 21;11(1):14905. doi: 10.1038/s41598-021-94090-y. Sci Rep. 2021. PMID: 34290287 Free PMC article.
Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study.
Wang A, Karunasinghe N, Plank L, Zhu S, Osborne S, Bishop K, Brown C, Schwass T, Masters J, Holmes M, Huang R, Keven C, Ferguson L, Lawrenson R. Wang A, et al. Among authors: masters j. Clin Med Insights Oncol. 2017 Oct 9;11:1179554917733449. doi: 10.1177/1179554917733449. eCollection 2017. Clin Med Insights Oncol. 2017. PMID: 29051709 Free PMC article.
Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N, Zhu Y, Han DY, Lange K, Zhu S, Wang A, Ellett S, Masters J, Goudie M, Keogh J, Benjamin B, Holmes M, Ferguson LR. Karunasinghe N, et al. Among authors: masters j. BMC Urol. 2016 Aug 2;16(1):48. doi: 10.1186/s12894-016-0164-4. BMC Urol. 2016. PMID: 27485119 Free PMC article.
Prostate disease risk factors among a New Zealand cohort.
Karunasinghe N, Han DY, Goudie M, Zhu S, Bishop K, Wang A, Duan H, Lange K, Ko S, Medhora R, Kan ST, Masters J, Ferguson LR. Karunasinghe N, et al. Among authors: masters j. J Nutrigenet Nutrigenomics. 2012;5(6):339-51. doi: 10.1159/000346279. Epub 2013 Jan 26. J Nutrigenet Nutrigenomics. 2012. PMID: 23363810 Free article.
Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.
Vaidyanathan V, Naidu V, Kao CH, Karunasinghe N, Bishop KS, Wang A, Pallati R, Shepherd P, Masters J, Zhu S, Goudie M, Krishnan M, Jabed A, Marlow G, Narayanan A, Ferguson LR. Vaidyanathan V, et al. Among authors: masters j. Mol Biosyst. 2017 Mar 28;13(4):681-698. doi: 10.1039/c6mb00873a. Mol Biosyst. 2017. PMID: 28252132 Free article.
557 results